Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena: This One-Trick Pony Is Safe to Short
Seeking Alpha
Wednesday, September 15, 2010 - 10:47am
tags:
Arena Pharmaceuticals, obesity, Abbott Laboratories, Meridia
Biodel's Linjeta Should Overcome the Usual FDA Approval Hurdles
Seeking Alpha
Wednesday, September 15, 2010 - 10:46am
tags:
FDA, Biodel, Linjeta, diabetes, MannKind, inhaled insulin, Afrezza, insulin injectables
Novo Nordisk to Double China R&D Headcount
Seeking Alpha
Wednesday, September 15, 2010 - 9:23am
tags:
R&D, Novo Nordisk, China
Analyst lowers rating on GlaxoSmithKline due to greater risk of Avandia withdrawals
Yahoo/AP
Wednesday, September 15, 2010 - 9:21am
tags:
Avandia, analysts, GSK
Live Blog: Odds Stacked Against FDA's Panel Approving Abbott's Meridia
Minyanville
Wednesday, September 15, 2010 - 8:08am
tags:
FDA, Meridia, Abbott Laboratories, obesity
Savient Investors Expect a Sale
TheStreet.com
Wednesday, September 15, 2010 - 8:06am
tags:
Savient, M&A, gout, FDA, Krystexxa, JNJ, Pfizer, Amgen, Novartis, Bristol-Myers Squibb
FDA extends time for AstraZeneca's ticagrelor NDA
Marketwatch
Wednesday, September 15, 2010 - 8:04am
tags:
AstraZeneca, FDA, Ticagrelor, Brilinta, anti-clotting
Sanofi Chief Says Genzyme Shareholders Will Sell for `Reasonable Price'
Bloomberg
Wednesday, September 15, 2010 - 7:39am
tags:
Genzyme, shareholders, Sanofi, Chris Viehbacher, M&A
Genzyme Cuts Back for Future Gains: Biotechs Must Revert to Lean Growth
Seeking Alpha
Wednesday, September 15, 2010 - 7:37am
tags:
layoffs, biotech, Genzyme, Amgen, Biogen Idec, Celgene, Gilead Sciences, Sanofi
Savient Pharmaceuticals' Krystexxa Approved for Gout
Bloomberg
Wednesday, September 15, 2010 - 7:35am
tags:
Savient, gout, Krystexxa, FDA
Neurocrine: depression drug ineffective in study
Yahoo/AP
Wednesday, September 15, 2010 - 7:34am
tags:
Neurocrine, depression, GSK
GlaxoSmithKline gets $21.3M defense contract
Yahoo/AP
Wednesday, September 15, 2010 - 7:27am
tags:
defense contracts, GSK
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tuesday, September 14, 2010 - 5:42pm
tags:
Arena Pharmaceuticals, obesity, Takeda, Orexigen, Contrave, Abbott Laboratories, Meridia, Qnexa, Vivus
2 Year-End FDA Run-Up Stock Plays
Seeking Alpha
Tuesday, September 14, 2010 - 5:41pm
tags:
FDA, pSivida, Alimera, Iluvien
Bayer resolves 200 Trasylol lawsuits
Fierce Pharma
Tuesday, September 14, 2010 - 11:40am
tags:
Bayer, lawsuits, settlements, Trasylol
K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval
NASDAQ.com
Tuesday, September 14, 2010 - 10:32am
tags:
KV Pharmaceutical, FDA
Cell Therapeutics to appeal FDA pixantrone decision
Bizjournals.com
Tuesday, September 14, 2010 - 10:21am
tags:
pixantrone, Cell Therapeutics, non-Hodgkin's lymphoma
Do rich markets lure biotechs away from low-cost remedies?
Fierce Biotech Research
Tuesday, September 14, 2010 - 10:19am
tags:
biotech, India, Brazil, China, South Africa
Arena's Lorcaserin: Therapeutic Value Zero?
Seeking Alpha
Tuesday, September 14, 2010 - 10:15am
tags:
Arena Pharmaceuticals, lorcaserin, obesity
BCA’s Brenner: Avastin And FDA Approval Standards
Pharmalot
Tuesday, September 14, 2010 - 10:14am
tags:
Avastin, FDA, breast cancer, Roche, Genentech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.